Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 10
Submit an article Journal homepage
290
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience

Luca LaurentiDepartment of Hematology, Catholic University of the Sacre Heart, Rome, ItalyCorrespondence[email protected]
,
Francesco AutoreDepartment of Hematology, Catholic University of the Sacre Heart, Rome, Italy
,
Idanna InnocentiDepartment of Hematology, Catholic University of the Sacre Heart, Rome, Italy
,
Barbara VannataDepartment of Hematology, Catholic University of the Sacre Heart, Rome, Italy
,
Nicola PiccirilloDepartment of Hematology, Catholic University of the Sacre Heart, Rome, Italy
,
Federica SoràDepartment of Hematology, Catholic University of the Sacre Heart, Rome, Italy
,
Domenico SpezialeDepartment of Laboratory Medicine, Catholic University of the Sacre Heart, Rome, Italy
,
Maurizio PompiliInternal Medicine, Catholic University of the Sacre Heart, Rome, Italy
,
Dimitar EfremovICGEB Outstation-Monterotondo, CNR Campus “A. Buzzati-Traverso”, Rome, Italy
&
Simona SicaDepartment of Hematology, Catholic University of the Sacre Heart, Rome, Italy
 show all
Pages 2841-2846 | Received 27 Nov 2014, Accepted 06 Feb 2015, Published online: 14 Mar 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Idanna Innocenti, Francesca Morelli, Francesco Autore, Andrea Corbingi, Raffaella Pasquale, Federica Sorà, Maurizio Pompili & Luca Laurenti. (2019) HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. Leukemia & Lymphoma 60:5, pages 1340-1342.
Read now
Jasleen K. Randhawa & Alessandra Ferrajoli. (2016) A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia. Expert Review of Hematology 9:3, pages 235-244.
Read now

Articles from other publishers (7)

Ahmet Murt, Tugrul Elverdi, Ahmet Emre Eskazan, Ayse Salihoglu, Muhlis Cem Ar, Seniz Ongoren, Zafer Baslar & Teoman Soysal. (2020) Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology 99:11, pages 2671-2677.
Crossref
Carmen Ka Man Cheung, Man Fai Law, David Chun Chao, Sunny Hei Wong, Rita Ho, Amelia Chien Wei Chao, Jennifer Wing Yan Lai, Ted Yun Tat Chan, Mark Tsz Kin Tam, Sam Lik Fung Lau & Tommy Ho Chi Tam. (2020) Prevention of hepatitis B virus reactivation in patients with hematological malignancies and resolved hepatitis B virus infection: a systematic review and meta‐analysis. Journal of Digestive Diseases 21:3, pages 160-169.
Crossref
Aldo Marrone, Marco Ciotti, Luca Rinaldi, Luigi Elio Adinolfi & Marc Ghany. (2019) Hepatitis B and C virus infection and risk of haematological malignancies. Journal of Viral Hepatitis 27:1, pages 4-12.
Crossref
Rhiannon M. Bath, Brandelyn E. Doering, Michael D. Nailor & Kellie J. Goodlet. (2018) Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review. Annals of Pharmacotherapy 53:3, pages 294-310.
Crossref
Shuchao Qin, Lei Fan, Jinhua Liang, Robert Gale, Yi Miao, Yujie Wu, Rong Wang, Hui Yang, Wei Wu, Yi Xia, Jiazhu Wu, Huayuan Zhu, Li Wang, Wei Xu & Jianyong Li. (2018) Definition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables. Hematological Oncology 36:4, pages 656-662.
Crossref
G. Gentile, M. Andreoni, G. Antonelli & L. Sarmati. (2017) Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review. Clinical Microbiology and Infection 23:12, pages 916-923.
Crossref
. (2016) Alemtuzumab/chlorambucil/rituximab. Reactions Weekly 1585:1, pages 23-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.